THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL

EHA Library, Aleksei Koviazin, 358209

THE POTENTIAL INFLUENCE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR–LIGAND MISMATCH ON THE PROGNOSIS OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE LEUKEMIA PATIENTS

EHA Library, Zoya Konova, 358206

THE IMPACT OF IMMUNOSUPPRESSION ON RECONSTITUTION OF CMV-SPECIFIC T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Anna Dmitrova, 358193

MULTICENTER RANDOMIZED CONTROLLED (COMPARATIVE) OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF THE R-DA-EPOCH-21 AND R-MNHL-BFM-90 ± AUTO- HSCT PROGRAMS IN PATIENTS WITH DE NOVO DIFFUSE B-CELL LAR

EHA Library, Aminat Magomedova, 358066

PROGNOSTIC VALUE OF TP53 VARIANTS IN CHILDREN WITH MATURE B-CELL LYMPHOMA TREATED ACCORDING TO REDUCED-INTENSITY B-NHL-2010M PROTOCOL

EHA Library, Volchkov Egor, 358036

PROGNOSTIC ROLE OF GENETIC ABNORMALITIES IN MANTLE CELL LYMPHOMA

EHA Library, Elizaveta Kleina, 357973

MEK-INHIBITORS IN TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS

EHA Library, Evgeniy Burtsev, 357957

COMPARISON OF NIVOLUMAB 40 MG EFFICACY VERSUS 3 MG/KG IN PATIENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA

EHA Library, Liudmila Fedorova, 357940

COVID19 SEVERITY AND THERAPEUTIC OPTIONS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Ekaterina Karimova, 357772

DIFFERENTIATION POTENTIAL AND RELATIVE GENE EXPRESSION LEVELS ARE CHANGED IN CFU-F FROM BONE MARROW OF APLASTIC ANEMIA PATIENTS AT THE ONSET OF THE DISEASE

EHA Library, Alena Dorofeeva, 357656

REARRANGEMENTS OF T-CELL RECEPTOR (TCR) LOCI IN CHILDREN WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Libuse Lizcova, 358607

DIFFERENTIAL IRON HOMEOSTASIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN VITRO MODELS

EHA Library, Martina Maria Capelletti, 358605

ASSESSMENT OF MIRNA BIOGENESIS GENES VARIANTS IN MDS DEVELOPMENT AND PROGRESSION

EHA Library, Dmitrii Bug, 357607

FIRST INTERIM RESULTS OF THE PROSPECTIVE STUDY OF DOSE REDUCTION AND DISCONTINUATION OF TYROSINE KINASE INHIBITORS (READIT-2020) IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE

EHA Library, Margarita Gurianova, 357564

TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA DURING COVID-19

EHA Library, Evgeniya Paramonova, 357226

THE INFLUENCE OF ACTIVE CARDIAC MONITORING WITH REMOTE CONTROL ON THE SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA, RECEIVING IBRUTINIB.

EHA Library, Elena Emelina, 357507

ASCIMINIB MANAGED-ACCESS PROGRAM (MAP) IN RUSSIA

EHA Library, Oleg Shukhov, 357580

IMMUNOPHENOTYPIC AND MOLECULAR GENETIC MARKERS OF UNFAVORABLE PROGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Anna Shevchenko, 357644

SIGNIFICANCE OF IHC AND BIOCHEMICAL MARKERS OF BONE METABOLISM FOR PREDICTING OSTEODESTRUCTIVE SYNDROME IN PLASMA CELL PROLIFERATION

EHA Library, Zhanna Kozich, 357779

SCREENING OF JAK2 EXON 12 SOMATIC MUTATIONS BY HIGH-RESOLUTION MELTING CURVE ANALYSIS

EHA Library, Dmitrij Kurochkin, 357916

HODGKIN LYMPHOMA IN PATIENTS WITH HIV: NATIONAL RETROSPECTIVE MULTICENTER STUDY

EHA Library, Andrey Chekalov, 357937

FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA

EHA Library, Nikita Mochkin, 357951

DIFFERENT MUTATIONS IN PATIENTS WITH PRIMARY LARGE B-CELL LYMPHOMA

EHA Library, Inna Kamaeva, 358055

CLINICAL HETEROGENEITY OF HIGH-GRADE B-CELL LYMPHOMA. EDGE OF TRANSFORMATION.

EHA Library, Anna Misyurina, 358070

COMPARISON OF NATURAL KILLER CELL RECONSTITUTION AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION DEPENDING ON THE VARIANT OF T-CELL DEPLETION

EHA Library, Zoya Konova, 358207

MONITORING OF DONOR CHIMERISM ON RED BLOOD CELLS ANTIGENS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Anna Yovdiy, 358245

THE ROLE OF INTESTINAL MICROBIOME IN SYSTEMIC INFECTIONS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Vitalii Chebotkevich, 358442

IN-HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASSESSMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID-19.

EHA Library, Diana Ivanova, 358443

ROLE OF HLA GENES IN DEVELOPMENT OF HLA-ALLOIMMUNIZATION IN BLOOD RECIPIENTS

EHA Library, Elena Butina, 358480

THE SEVERITY OF HEMORRHAGIC SYNDROME AND THE WEAKENING OF THE PROCOAGULANT ACTIVITY OF PLATELETS IN PATIENTS WITH WISKOTT-ALDRICH SYNDROME.

EHA Library, Dmitrii Polokhov, 358502

VKORC1 -1639 G/A GENE POLYMORPHISM CAN MODULATE THE RISK OF VENOUS THROMBOEMBOLISM IN ELDERLY PATIENTS WITH FV LEIDEN MUTATION

EHA Library, Sergey Kapustin, 358545

APOPTOTIC EFFECT OF FLUMATINIB COMBINED WITH BCL2 INHIBITOR ON PH+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Zheng Ge, 358606

ALTERATIONS IN THE GUT MICROBIOME IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Meerim Park, 358608

IBRUTINIB PLUS VENETOCLAX IN PATIENTS WITH COMPLEX KARYOTYPE AND CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Andrei Petrenko, 357516

DIFFERENCES IN GENE EXPRESSION PATTERN AND IMMUNOPHENOTYPE OF BONE MARROW MULTIPOTENT MESENCHYMAL STROMAL CELLS IN PATIENTS AT THE ONSET OF ACUTE LEUKEMIA AND AFTER ACHIEVING REMISSION

EHA Library, Aleksandra Sadovskaya, 357304

NEW LYMPHOABLATIVE CONDITIONING REGIME FOR MULTIPLE SCLEROSIS – FIRST RESULTS FROM RUSSIAN PILOT STUDY

EHA Library, Anatolij Rukavitcyn, 358224

COMPARISON CONDITIONING REGIMENS (BEEAC,LEAM,CLV) BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION FOR TREATMENT OF PRIMARY-REFRACTORY AND RELAPSED FORMS HODGKIN'S LYMPHOMA

EHA Library, Anastasiia Samoylova, 358225

EFFECT OF NUTRITIONAL SUPPORT ON THE INCIDENCE OF MUCOSITIS IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN PATIENTS WITH HODGKIN'S LYMPHOMA. (INTERIM RESULTS)

EHA Library, Stanislav Volchenkov, 358242

ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19

EHA Library, Tatiana Chudnova, 358431

THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND CONCOMITANT COVID-19 INFECTION

EHA Library, Yuri Polyakov, 358456

ANTIGENS OF THE DUFFY BLOOD GROUP SYSTEM AND RISK OF COVID-19 INFECTION

EHA Library, Elena Poponina, 358457

CENTRAL VEIN CATHETERISATION IN ONCOHEMATOLOGICAL PATIENTS: COMPLICATION, ASSOCIATED WITH PROCEDURA AND CARE

EHA Library, Nikolay Romanenko, 358463

ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS: FEATURES OF TREATMENT IN CONTEXT OF THE COVID-19 PANDEMIC.

EHA Library, Tatyana Tolstykh, 358469

GENES POLYMORPHISM OF THROMBOPHILIA AND PROTHROMBOTIC CONDITIONS IN WOMEN WITH VARIOUS OBSTETRIC ANAMNESIS

EHA Library, Anastasia Zagarskikh, 358528

GENETIC POLYMORPHISM OF PLASMA HEMOSTATIC FACTORS AND THE RISK OF DEEP VEIN THROMBOSIS IN ELDERLY AND SENILE PATIENTS

EHA Library, Anna Chechulova, 358536

QUALITY OF LIFE AND UNMET NEEDS AMONG PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASM PATIENTS: RESULTS OF THE NATIONWIDE SURVEY

EHA Library, Tatyana Ionova, 358581

ADHERENCE TO TREATMENT OF HEMATOLOGICAL MALIGNANCIES PATIENTS WITH ANXIETY AND DEPRESSION

EHA Library, Dmitry E Vybornykh, 358602

Abstract Book 2022

EHA Library, Faculty / Presenters, 400188

Current developments in CD123-positive haematological malignancies

EHA Library, Stemline, 372499

How I Treat: Chimeric antigen receptor T(CAR-T) in Clinical Practice for lymphomas and leukemias

EHA Library, Novartis, 372498

Unmet needs and future possibilities for paroxysmal nocturnal hemoglobinuria (PNH): hear the patient perspective and expert opinions

EHA Library, Novartis, 372495

Exploring unmet needs and therapeutic targets for immune thrombocytopenia and warm autoimmune hemolytic anemia

EHA Library, Novartis, 372494

F. Hoffmann-La Roche Ltd.

EHA Library, F. Hoffmann-La Roche Ltd., 372493

Immunotherapy: evolution or revolution in the cure of multiple myeloma

EHA Library, Janssen, 372492

Immunotherapies: Rising to the challenge of relapsed/refractory multiple myeloma

EHA Library, Janssen, 372491

Refining care and improving outcomes in immune thrombocytopenia (ITP) patients

EHA Library, Grifols, 372488

T-cell Engaging Bispecific Antibodies: A New Era in the Management of Relapsed/Refractory Follicular Lymphoma

EHA Library, F. Hoffmann-La Roche Ltd., 372487

Advancing C5 Inhibitor Therapy: Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease

EHA Library, F. Hoffmann-La Roche Ltd., 372486

Advancements in the treatment of B-cell malignancies

EHA Library, BMS, 372484

Expert Insights into β-thalassemia Management

EHA Library, BMS, 372480

Biosimilars for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment: What Rare Disease Experts Should Know

EHA Library, Amgen, 372477

Bruton's tyrosine kinase (BTK) inhibition in B-Cell Malignancies – A critical target for effective and safe treatment

EHA Library, BeiGene, 372479

When to Consider Re-evaluation of Therapy for Myelofibrosis: Understanding and Managing Treatment Failure

EHA Library, BMS, 372481

Recent advancements in immune therapies for multiple myeloma

EHA Library, BMS, 372482

Myelodysplastic syndrome (MDS) and Acute Myeloid Leukemia (AML): from Trials to Practice

EHA Library, BMS, 372483

Advancing CAR T cell therapies in B-cell malignancies

EHA Library, BMS, 372485

Minimal residual disease (MRD): the big question mark in Chronic Lymphocytic Leukemia (CLL)?

EHA Library, Janssen, 372490

Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk Myelodysplastic syndrome (MDS) Treatment

EHA Library, Novartis, 372496

The human impact of chronic myeloid leukemia (CML) after 2 TKIs: What does the data mean for patients and the clinical practice?

EHA Library, Novartis, 372497

Optimizing treatment selection and sequencing for patients with multiple myeloma: A precision medicine approach

EHA Library, Janssen, 372489

Abstract Book 2021

EHA Library, Faculty / Presenters, 400187

FIXED-DURATION IBRUTINIB AND VENETOCLAX (I+V) VERSUS CHLORAMBUCIL PLUS OBINUTUZUMAB (CLB+O) FOR FIRST-LINE (1L) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): PRIMARY ANALYSIS OF THE PHASE 3 GLOW STUDY

EHA Library, Arnon Philip Kater, 330172

SAFETY AND EFFICACY OF CD37-TARGETING NARATUXIMAB EMTANSINE PLUS RITUXIMAB IN DIFFUSE LARGE B-CELL LYMPHOMA AND OTHER NON-HODGKIN’S B-CELL LYMPHOMAS - A PHASE 2 STUDY

EHA Library, Moshe Yair Levy, 330173

A COMPARISON OF CLINICAL OUTCOMES FROM ZUMA-5 (AXICABTAGENE CILOLEUCEL) AND THE INTERNATIONAL SCHOLAR-5 EXTERNAL CONTROL COHORT IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)

EHA Library, John Gribben, 330174

OVERALL SURVIVAL RESULTS WITH DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: PHASE 3 MAIA STUDY

EHA Library, Thierry Facon, 330171

FIRST INTERIM ANALYSIS OF ALPINE STUDY: RESULTS OF A PHASE 3 RANDOMIZED STUDY OF ZANUBRUTINIB VS IBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA

EHA Library, Peter Hillmen, 330170

ACUTE TOXICITY OF R-CHOP PROTOCOL IN THE TREATMENT OF NON-HODGKIN'S LYMPHOMA : ABOUT 551 CYCLES

EHA Library, Emna Ines Saidi, 324123

NEUTROPHIL/LYMPHOCYTE RATIO (NLR) ITS A WORSE PROGNOSIS FACTOR IN OVERALL SURVIVAL IN LARGE B CELL LYMPHOMA (DLBCL). EXPERIENCE IN HEMATOLOGY CENTER IN NORTHEAST OF MEXICO

EHA Library, Guillermo Sotomayor Duque, 324118

DISPARITIES IN LYMPHOMA SURVIVORSHIP ACCORDING TO SOCIO-DEMOGRAPHIC FACTORS; SINGLE CENTER RETROSPECTIVE STUDY IN A COHORT OF 253 DLBCL PATIENTS TREATED WITH RCHOP

EHA Library, Emmanouil Spanoudakis, 324116

ESCALADE: ACALABRUTINIB + RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE (R-CHOP) IN UNTREATED NON-GERMINAL CENTER B-CELL–LIKE (NON-GCB) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Laurie Sehn, 324114

ABNORMAL AND COMPLEX KARYOTYPE IS FREQUENT ON ROUTINE KARYOTYPING ON PRIMARY TISSUE IN PATIENTS WITH DIFFUSE LARGE B-CELL AND TRANSFORMED LYMPHOMA BUT DOES NOT INFLUENCE CLINICAL OUTCOMES

EHA Library, Ray Mun Koo, 324113

RELATIONSHIP BETWEEN PAKT1, PSYK PROTEINS CO-EXPRESSION AND SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Vaneeva, 324112

RELATIONSHIP BETWEEN GENETIC ABERRATIONS IN THE 17P13/TP53 LOCUS AND IMMUNOHISTOCHEMICAL PROTEIN P53 EXPRESSION IN TUMOR CELLS OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Maria Berdnikova, 324111

TWO CASE REPORT: CONCURRENT CROHN'S DISEASE AND MYELODYSPLASTIC SYNDROME OR ACUTE LEUKEMIA

EHA Library, Zaineb Mlayah, 324108

REAL-LIFE EFFICACY OF FIXED-DOSE HYPOMETHYLATING AGENTS IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE

EHA Library, Tarinee Rungjirajittranon, 324100

CHILDREN ACUTE PROMYELOCYTIC LEUKEMIA: HEMATOLOGY DEPARTMENT EXPERIENCE AT AZIZA OTHMANA HOSPITAL

EHA Library, Rym Jaidi, 324104

OUTCOME OF TREATING PEDIATRIC LANGERHANS HISTIOCYTOSIS WITH LCH III IN TERTIARY CENTER, SAUDI ARABIA.

EHA Library, Abrar AlMohammadi, 324103

T(6;9)(P22;Q34)/DEK-NUP214-POSITIVE ACUTE MYELOID LEUKEMIA IN ADULTS IS A RARE POOR PROGNOSIS SUBTYPE AFFECTING YOUNGER PATIENTS: THE BULGARIAN EXPERIENCE

EHA Library, Gueorgui Balatzenko, 324102

SAFETY AND FEASIBILITY OF HIGH DOSE CHEMOTHERAPY WITH PBSC RESCUE AND ASCT CONSOLIDATION IN PCNSL: A SINGLE CENTER EXPERIENCE

EHA Library, Emanuele Ravano, 324122

BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN SUBJECTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (TRIAL IN PROGRESS)

EHA Library, Nancy L. Bartlett, 324121

PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE PLUS RITUXIMAB VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) - LOTIS-5

EHA Library, Carmelo Carlo-Stella, 324120

HEALTH-RELATED QUALITY OF LIFE EFFECT OF MOGAMULIZUMAB BY PATIENT BLOOD INVOLVEMENT

EHA Library, Pier Luigi Zinzani, 324119

OUTCOME OF PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA AFTER HIGH-DOSE METHOTREXATE FOLLOWED BY CONSOLIDATION WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE: AN 8-YEAR COHORT STUDY

EHA Library, Pokpong Piriyakhuntorn, 324117

BENDAMUSTINE IS A FAVORABLE LYMPHODEPLETING CHEMOTHERAPY REGIMEN PRIOR TO CAR T CELLS IMMUNOTHERAPY AS FLUDARABINE

EHA Library, Peihao Zheng, 324115

CAR-T CELL THERAPY FOR PEOPLE WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A COCHRANE SYSTEMATIC REVIEW

EHA Library, Moritz Ernst, 324110

THE CORRELATION BETWEEN SKIN RESPONSE AND BLOOD INVOLVEMENT WITH MOGAMULIZUMAB

EHA Library, Pietro Quaglino, 324109

TAGRAXOFUSP AS FIRST-LINE TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN). A CASE REPORT

EHA Library, Clara Navajas Laguna, 324107

THERAPY-RELATED MYELOID NEOPLASMS: A DESCRIPTIVE ANALYSIS AT A SINGLE INSTITUTION

EHA Library, Beatriz Merchan Muñoz, 324106

CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA: RESULTS OF A TUNISIAN EXPERIENCE

EHA Library, Hend Ben Neji, 324101

ALL-TRANS RETINOIC ACID INDUCED MYOCARDITIS AS PART OF DIFFERENTIATION SYNDROME: A CASE REPORT AND LITERATURE REVIEW

EHA Library, Na Kim, 324105